Skip to main content
Top
Published in: Surgery Today 4/2024

14-07-2023 | Colorectal Cancer | Original Article

Correlations of age with clinicopathological features, perioperative outcomes and the prognosis in patients with colorectal cancer: a Japanese multicenter study

Authors: Tetsuro Tominaga, Takashi Nonaka, Shintaro Hashimoto, Toshio Shiraishi, Keisuke Noda, Makoto Hisanaga, Hiroaki Takeshita, Hidetoshi Fukuoka, Terumitsu Sawai, Takeshi Nagayasu

Published in: Surgery Today | Issue 4/2024

Login to get access

Abstract

Purpose

Colorectal cancer is not common in patients under 40 years old, and its associations with clinical features and the prognosis remain uncertain.

Methods

Using a multicenter database, we retrospectively reviewed 3015 patients who underwent colorectal surgery between 2016 and 2021. Patients were divided by age into those < 40 years old (young; n = 52), 40–54 years old (middle-aged; n = 254) and > 54 years old (old; n = 2709). We then investigated age-related differences in clinicopathological features, perioperative outcomes and the prognosis.

Results

The proportion of young patients increased annually from 0.63% in 2016 to 2.10% in 2021. Female patients were more frequent, the performance status was better, tumors were larger, clinically node-positive and poorly differentiated adenocarcinomas were more frequent, postoperative complications were less frequent, and the hospital stay was shorter in young patients than in older patients. Young age was an independent predictor of a low risk of postoperative complications (odds ratio, 0.204; 95% confidence interval, 0.049–0.849; p = 0.028). With pathologically node-positive status, adjuvant chemotherapy was more frequent in young patients (100%) than in middle-aged (73.7%) or old (51.8%) patients (p < 0.001), and the 3-year relapse-free survival was better in the young group than in others.

Conclusion

Despite higher rates of advanced tumors in younger patients, adequate adjuvant chemotherapy appears to improve the relapse-free survival.
Appendix
Available only for authorised users
Literature
2.
go back to reference Safford KL, Spebar MJ, Rosenthal D. Review of colorectal cancer in patients under age 40 years. Am J Surg. 1981;142(6):767–9.CrossRefPubMed Safford KL, Spebar MJ, Rosenthal D. Review of colorectal cancer in patients under age 40 years. Am J Surg. 1981;142(6):767–9.CrossRefPubMed
3.
go back to reference Rodrigues MA, Breim LC, Mendes EF, de Macedo AR, Franco M. Colorectal adenocarcinoma in patients under 40. Report of 11 cases. AMB Revista da Associacao Medica Brasileira. 1985;31(11–12):223–6.PubMed Rodrigues MA, Breim LC, Mendes EF, de Macedo AR, Franco M. Colorectal adenocarcinoma in patients under 40. Report of 11 cases. AMB Revista da Associacao Medica Brasileira. 1985;31(11–12):223–6.PubMed
4.
go back to reference Adloff M, Arnaud JP, Schloegel M, Thibaud D, Bergamaschi R. Colorectal cancer in patients under 40 years of age. Dis Colon Rectum. 1986;29(5):322–5.CrossRefPubMed Adloff M, Arnaud JP, Schloegel M, Thibaud D, Bergamaschi R. Colorectal cancer in patients under 40 years of age. Dis Colon Rectum. 1986;29(5):322–5.CrossRefPubMed
5.
go back to reference Domergue J, Ismail M, Astre C, Saint-Aubert B, Joyeux H, Solassol C, et al. Colorectal carcinoma in patients younger than 40 years of age. Montpellier cancer institute experience with 78 patients. Cancer. 1988;61(4):835–40.CrossRefPubMed Domergue J, Ismail M, Astre C, Saint-Aubert B, Joyeux H, Solassol C, et al. Colorectal carcinoma in patients younger than 40 years of age. Montpellier cancer institute experience with 78 patients. Cancer. 1988;61(4):835–40.CrossRefPubMed
6.
go back to reference Chou CL, Chang SC, Lin TC, Chen WS, Jiang JK, Wang HS, et al. Differences in clinicopathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institution. Am J Surg. 2011;202(5):574–82.CrossRefPubMed Chou CL, Chang SC, Lin TC, Chen WS, Jiang JK, Wang HS, et al. Differences in clinicopathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institution. Am J Surg. 2011;202(5):574–82.CrossRefPubMed
7.
go back to reference Yamamoto S, Inomata M, Katayama H, Mizusawa J, Etoh T, Konishi F, et al. JCOG0404 Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan clinical oncology group study JCOG 0404. Ann Surg. 2014;260(1):23–30.CrossRefPubMed Yamamoto S, Inomata M, Katayama H, Mizusawa J, Etoh T, Konishi F, et al. JCOG0404 Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan clinical oncology group study JCOG 0404. Ann Surg. 2014;260(1):23–30.CrossRefPubMed
8.
go back to reference Cho MM, Morgan JW, Knutsen R, Oda K, Shavlik D, Knutsen S, et al. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994–2009. Dis Colon Rectum. 2013;56(12):1357–65.CrossRefPubMed Cho MM, Morgan JW, Knutsen R, Oda K, Shavlik D, Knutsen S, et al. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994–2009. Dis Colon Rectum. 2013;56(12):1357–65.CrossRefPubMed
9.
go back to reference Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hashiguchi T, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25(1):1–42.CrossRefPubMed Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hashiguchi T, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25(1):1–42.CrossRefPubMed
10.
go back to reference Steele SR, Chen SL, Stojadinovic A, Nissan A, Zhu K, Peoples GE, et al. The impact of age on quality measure adherence in colon cancer. J Am Coll Surg. 2011;213(1):95–103 (discussion 4-5).CrossRefPubMedPubMedCentral Steele SR, Chen SL, Stojadinovic A, Nissan A, Zhu K, Peoples GE, et al. The impact of age on quality measure adherence in colon cancer. J Am Coll Surg. 2011;213(1):95–103 (discussion 4-5).CrossRefPubMedPubMedCentral
11.
go back to reference Taggarshe D, Rehil N, Sharma S, Flynn JC, Damadi A. Colorectal cancer: are the “young” being overlooked? Am J Surg. 2013;205(3):312–6 (discussion 6).CrossRefPubMed Taggarshe D, Rehil N, Sharma S, Flynn JC, Damadi A. Colorectal cancer: are the “young” being overlooked? Am J Surg. 2013;205(3):312–6 (discussion 6).CrossRefPubMed
12.
go back to reference Heys SD, Sherif A, Bagley JS, Brittenden J, Smart C, Eremin O. Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg. 1994;81(5):685–8.CrossRefPubMed Heys SD, Sherif A, Bagley JS, Brittenden J, Smart C, Eremin O. Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg. 1994;81(5):685–8.CrossRefPubMed
13.
go back to reference Ganapathi S, Kumar D, Katsoulas N, Melville D, Hodgson S, Finlayson C, et al. Colorectal cancer in the young: trends, characteristics and outcome. Int J Colorectal Dis. 2011;26(7):927–34.CrossRefPubMed Ganapathi S, Kumar D, Katsoulas N, Melville D, Hodgson S, Finlayson C, et al. Colorectal cancer in the young: trends, characteristics and outcome. Int J Colorectal Dis. 2011;26(7):927–34.CrossRefPubMed
14.
go back to reference You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med. 2012;172(3):287–9.CrossRefPubMed You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med. 2012;172(3):287–9.CrossRefPubMed
15.
go back to reference O’Connell JB, Maggard MA, Livingston EH, Yo CK. Colorectal cancer in the young. Am J Surg. 2004;187(3):343–8.CrossRefPubMed O’Connell JB, Maggard MA, Livingston EH, Yo CK. Colorectal cancer in the young. Am J Surg. 2004;187(3):343–8.CrossRefPubMed
16.
go back to reference Shemesh-Bar L, Kundel Y, Idelevich E, Sulkes J, Sulkes A, Brenner B. Colorectal cancer in young patients in Israel: a distinct clinicopathological entity? World J Surg. 2010;34(11):2701–9.CrossRefPubMed Shemesh-Bar L, Kundel Y, Idelevich E, Sulkes J, Sulkes A, Brenner B. Colorectal cancer in young patients in Israel: a distinct clinicopathological entity? World J Surg. 2010;34(11):2701–9.CrossRefPubMed
17.
go back to reference Li M, Li JY, Zhao AL, Gu J. Do young patients with colorectal cancer have a poorer prognosis than old patients? J Surg Res. 2011;167(2):231–6.CrossRefPubMed Li M, Li JY, Zhao AL, Gu J. Do young patients with colorectal cancer have a poorer prognosis than old patients? J Surg Res. 2011;167(2):231–6.CrossRefPubMed
18.
go back to reference André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–51.CrossRefPubMed André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–51.CrossRefPubMed
19.
go back to reference Kuebler JP, Wieand HS, O’Connell MJ, Smith RE, Colangelo LH, Yothers G, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(16):2198–204.CrossRef Kuebler JP, Wieand HS, O’Connell MJ, Smith RE, Colangelo LH, Yothers G, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(16):2198–204.CrossRef
20.
go back to reference Yothers G, O’Connell MJ, Allegra CJ, Kuebler JP, Colangelo LH, Petrelli NJ, et al. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(28):3768–74.CrossRef Yothers G, O’Connell MJ, Allegra CJ, Kuebler JP, Colangelo LH, Petrelli NJ, et al. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(28):3768–74.CrossRef
21.
go back to reference Gandhi J, Davidson C, Hall C, Pearson J, Eglinton T, Wakeman C, et al. Population-based study demonstrating an increase in colorectal cancer in young patients. Br J Surg. 2017;104(8):1063–8.CrossRefPubMed Gandhi J, Davidson C, Hall C, Pearson J, Eglinton T, Wakeman C, et al. Population-based study demonstrating an increase in colorectal cancer in young patients. Br J Surg. 2017;104(8):1063–8.CrossRefPubMed
22.
go back to reference Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer. 2010;116(18):4354–9.CrossRefPubMed Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer. 2010;116(18):4354–9.CrossRefPubMed
Metadata
Title
Correlations of age with clinicopathological features, perioperative outcomes and the prognosis in patients with colorectal cancer: a Japanese multicenter study
Authors
Tetsuro Tominaga
Takashi Nonaka
Shintaro Hashimoto
Toshio Shiraishi
Keisuke Noda
Makoto Hisanaga
Hiroaki Takeshita
Hidetoshi Fukuoka
Terumitsu Sawai
Takeshi Nagayasu
Publication date
14-07-2023
Publisher
Springer Nature Singapore
Published in
Surgery Today / Issue 4/2024
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-023-02724-7

Other articles of this Issue 4/2024

Surgery Today 4/2024 Go to the issue